Floatz logo

HYDROXYETHYL STARCH

Stroke Patients Presenting Within 24 Hrs of Onset of Symptoms

Nizam's Institute of Medical Sciences University, IndiaOtherN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

133 Active assets in the Stroke Patients Presenting Within 24 Hrs of Onset of Symptoms cohort.

Asset / SponsorPhaseRating
INCOBOTULINUMTOXINA
Parc de Salut Mar
Phase 4BBB
Aggrenox
Boehringer Ingelheim
Phase 4BBB
ATENOLOL
Northern California Institute of Research and Education
Phase 4BBB
Dextromethorphan
University of Florida
Phase 4BBB
Tenecteplase
Assistance Publique - Hôpitaux de Paris
Phase 4BBB

View all 50 →

Same molecule, other indications

HYDROXYETHYL STARCH is also rated in:

Fluid ResponsivenessDormant
D
Indicative ·
30 / 100
View asset →
Prone PositionDormant
D
Indicative ·
30 / 100
View asset →
Non Invasive Cardiac Output MonitoringDormant
D
Indicative ·
30 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →